Form D · Pharmaceuticals
AIKO BIOTECHNOLOGY INC
Portland, ME · CIK 0001391914
Offering snapshot reported Dec 3, 2009 · SEC filing
- Reported sold
- $850K Offering amount: $850K
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 5, 2009 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 3, 2009 | Amendment | $850,000 | No comparison | 0 | SEC filing |
| Sep 28, 2009 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 23, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06, 46
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-100679
Conversion of principal and interest in aggregate amount of approximately $850,000.
Source: Form D, filed Dec 3, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| David Anderson | Director |
| Edward Bilsky | Director |
| William Emheiser | Executive, Promoter |
| Victor C. Otley, Iii | Director, Executive, Promoter |
| Wolfgang Sadee | Director, Executive, Promoter |
| Janet Yancey Wrona | Executive, Promoter |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2 Union Street Suite 501
Portland, ME, 04101
Portland, ME, 04101